Medifast (NYSE:MED) Stock Rating Upgraded by StockNews.com
Medifast (NYSE:MED – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Monday. Separately, DA Davidson cut their price objective on shares of Medifast from $93.00 to $80.00 and set a “neutral” rating on the stock in a report on […]